LFVN — Lifevantage Corp
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 849146 ·
Last close
$6.84
Market Cap
$86.29M
52W High
$11.71
52W Low
$5.52
ADV30
67,859
Next earnings
2026-08-27
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 43,716,000 | 34,544,000 | 1,678,000 | 1,362,000 | 62,127,000 | 12,483,000 | 28,788,000 |
| Dec 2025 | 48,931,000 | 36,209,000 | 487,000 | 276,000 | 61,169,000 | 10,181,000 | 28,182,000 |
| Sep 2025 | 47,561,000 | 37,816,000 | 2,268,000 | 2,155,000 | 61,579,000 | 13,091,000 | 28,422,000 |
| Jun 2025 | 55,114,000 | 44,049,000 | 2,148,000 | 1,959,000 | 71,958,000 | 20,201,000 | 37,317,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$6,508,000
Investing CF
$-6,476,000
Financing CF
$-9,876,000
CapEx
$-2,733,000
Dividends Paid
$-2,281,000
Buybacks
$-6,280,000
EPS Diluted TTM
$0.45
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-103,656,000
Inventory
$18,382,000
Receivables
$4,620,000
ST Investments
—
EBIT TTM
$6,581,000
Pretax Income TTM
$6,766,000
Interest Exp TTM
—
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$195,323,008
EBITDA
$10,007,000
Free Cash Flow
$2,032,125
Enterprise Value
$82,122,848
Total Cash
$12,483,000
Total Debt
$10,206,000
Shares Out
12,615,822
Trailing EPS
$0.45
Book Value
$2.64
ROE
17.1%
ROA
6.4%
Div Yield
3.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Jun 2025 | 228,530,000 | 12,199,000 | 9,805,000 | 71,958,000 | 37,317,000 | — | 11,878,000 |
| Jun 2024 | 200,164,000 | 4,332,000 | 2,937,000 | 60,299,000 | 34,308,000 | — | 12,197,000 |
| Jun 2023 | 213,398,000 | 4,259,000 | 2,540,000 | 66,123,000 | 31,474,000 | — | 6,828,000 |
| Jun 2022 | 206,360,000 | 7,575,000 | 3,120,000 | 70,706,000 | 39,190,000 | — | 7,959,000 |
TTM Snapshot
Revenues TTM
$203,560,000
NetIncome TTM
$5,546,000
OpCashFlow TTM
$0
Assets (Latest)
$60,299,000
Forward EPS
$0.46
Max Pain — expiry 2026-09-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $5.00 · spot: $6.84 · call volume: 124 · put volume: 35
Expected Move to 2026-09-18:
±$2.65
(38.74%) —
implied range
$4.19 –
$9.49
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RVRC | Revium Rx. | $86.84M | $1.43 | — |
| DWTX | Dogwood Therapeutics, Inc. | $87.02M | $2.56 | — |
| GOSS | Gossamer Bio, Inc. | $85.55M | $0.17 | — |
| GANX | Gain Therapeutics, Inc. | $87.29M | $2.00 | — |
| PLYX | Polaryx Therapeutics, Inc. | $88.53M | $1.87 | — |
News headlines (Yahoo Finance, 1h cache)
LifeVantage Declares Quarterly Dividend
2026-08-21 12:00 · Yahoo
LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2026 Results on August 27, 2026
2026-08-13 20:30 · Yahoo
LifeVantage Corporation (NASDAQ:LFVN) Pays A US$0.05 Dividend In Just Three Days
2026-05-28 11:01 · Yahoo
Do Options Traders Know Something About LifeVantage Stock We Don't?
2026-05-27 15:28 · Yahoo
Lake Street Capital Markets Downgrades LifeVantage Corporation (LFVN) After Weak Q3 Results
2026-05-14 05:29 · Yahoo
LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2026
2026-05-06 20:05 · Yahoo
How A Reset Price Target Is Shaping The Evolving Story For LifeVantage (LFVN)
2026-05-03 18:06 · Yahoo
LifeVantage to Announce Third Quarter Fiscal Year 2026 Results on May 6, 2026
2026-04-22 20:05 · Yahoo
LifeVantage Corporation Q3 2026 Earnings Call Summary
2026-05-07 00:28 · Yahoo
Strength Seen in Lifevantage (LFVN): Can Its 8.5% Jump Turn into More Strength?
2026-04-28 10:48 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.